35
Participants
Start Date
April 8, 2024
Primary Completion Date
September 30, 2025
Study Completion Date
March 31, 2026
Dobutrex
Dobutamine (Dobutrex®) infusion. will be performed with a stepwise dobutamine dosage increase every 5 minutes (2,3,5,10,20 ug/kg/min). Dobutamine dosage will only be increased to 40 ug/kg/min in participants with ongoing beta-blocker treatment to ensure an appropriate dobutamine response. As dobutamine and its metabolites are excreted renally, the dose will be reduced to max 10 ug/kg/min in participants with eGFR below 30 mL/min/1,73 m2. Echocardiography, blood pressure, heart rate, and invasive pressure and flow measurements will be obtained before the infusion starts, at each infusion stage, and during the recovery period after the infusion is stopped.
RECRUITING
Department of Cardiology, Aarhus University Hospital, Aarhus
Steen Hvitfeldt Poulsen
OTHER